Biointerfaces Background 01

Category: Translational Research

BI Startup EVOQ Therapeutics wins Grand Prize at Accelerate Michigan Innovation Competition
November 25, 2019

EVOQ Therapeutics, an Ann Arbor-based startup focused on developing cancer immutherapies, has won the grand prize at the tenth Accelerate Michigan Innovation Competition. The company is based on technology developed by BI faculty members, James Moon and Anna Schwendeman.

Read Story
Cardiovascular Diseases Challenge Seed Fund Awards
September 4, 2019

We are pleased to announce the funding selections for the BI Engineering Approaches to Cardiovascular Diseases Challenge.

Read Story
The Shea group investitages antigen-conjugated nanoparticle treatment
UM Invests in BI Startup Greenmark Biomedical
February 22, 2019

Through the Michigan Investment in New Technology Startups (MINTS) initiative, UM will invest $500K in GreenMark Medical, a startup based on technologies developed by BI Director, Joerg Lahann.

Read Story
Default Featured Image
BI Startup Evoq Therapeutics profiled in Crain’s Detroit
January 3, 2019

Crain’s Detroit features Evoq Therapeutics, a startup company co-founded by James Moon and Anna Schwendeman.

Read Story

The Biointerfaces Institute brings extensive experience to the collaborations that lead to scientific breakthroughs, successful translation, and advanced learning.

Work With Us